Erythema multiforme: A review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis

Dental Clinics of North America

Volumn 49, Issue 1 SPEC.ISS., 2005, Pages 67-76

  Williams, P Michele ^a,b   Conklin, Robert J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTICONVULSIVE AGENT; CARBAMAZEPINE; COTRIMOXAZOLE; HYDANTOIN; PENICILLIN G; PREDNISONE; STEROID; SULFONAMIDE; TERBINAFINE; VALPROIC ACID;

CLINICAL FEATURE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHEMA MULTIFORME; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MOUTH INFECTION; MOUTH MUCOSA; PATHOPHYSIOLOGY; RASH; REVIEW; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 9444236712     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2004.08.003     Document Type: Review

References (29)

1. P.O. Fritsch, and R. Ruiz-Maldonado Erythema multiforme I. Freedberg Fitzpatrick's dermatology in general medicine 5th edition 1999 McGraw Hill New York 636 644
2. M. Mockenhaupt, and E. Schopf Epidemiology of drug-induced severe skin reactions Semin Cutan Med Surg 15 1996 236 242
3. J.K. Schofield, F.M. Tatnall, and I.M. Leigh Recurrent erythema multiforme: clinical features and treatment in a large series of patients Br J Dermatol 128 1993 542 545
4. J. Revuz, D. Penson, J.C. Roujeau, J.C. Guillaume, C.R. Payne, and J. Wechsler Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients Arch Dermatol 123 1993 1160 1165
5. J.C. Roujeau, T.N. Huynh, C. Bracq, J.C. Guillaume, J. Revuz, and R. Touraine Genetic susceptibility to toxic epidermal necrolysis Arch Dermatol 123 1987 1171 1173
6. P. Saiag, E. Caumes, O. Chosidow, J. Revus, and J.C. Roujeau Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus J Am Acad Dermatol 26 1992 567 574
7. H. Assier, S. Bastuji-Garin, J. Revus, and J.C. Roujeau Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are different disorders with distinct causes Arch Dermatol 131 1995 539 543
8. J.C. Roujeau The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification J Invest Dermatol 102 1994 28S 30S
9. S. Bastuji-Garin, B. Rzany, R.S. Stern, N.H. Shear, L. Naldi, and J.C. Roujeau Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch Dermatol 129 1993 92 96
10. A. Auquier-Dunant, M. Mockenhaupt, L. Naldi, O. Correia, W. Schroder, and J.C. Roujeau Correlations between clinical patterns and causes of erythema multiforme major, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Results of an international prospective study Arch Dermatol 138 2002 1019 1024
11. W.W. Howland, L.E. Golitz, W.L. Weston, and J.C. Huff Erythema multiforme: clinical, histopathologic, and immunologic study J Am Acad Dermatol 10 1984 438 446
12. S.L. Brice, M.A. Leahy, L. Ong, S. Krecji, S.S. Stockert, and J.C. Huff Examination of non-involved skin, previously involved skin, and peripheral blood for herpes simplex virus DNA in patients with recurrent herpes-associated erythema multiforme J Cutan Pathol 21 1994 408 412
13. F.M. Tatnall, J.K. Schofield, and I.M. Leigh A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme Br J Dermatol 132 1995 267 270
14. J.C. Roujeau, J.P. Kelly, L. Naldi, B. Rzany, R.S. Stern, and T. Anderson Medication use and the risk of Steven-Johnson syndrome or toxic epidermal necrolysis N Engl J Med 333 1995 1600 1608
15. O. Correia, O. Chosidow, P. Saiag, S. Bastuji-Garin, J. Revuz, and J.C. Roujeau Evolving pattern of drug-induced toxic epidermal necrolysis Dermatology 186 1993 32 37
16. C. Leaute-Labreze, T. Lamireau, D. Chawki, J. Maleville, and A. Taieb Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome Arch Dis Child 83 2000 347 352
17. L. Aurelian, F. Ono, and J. Burnett Herpes simplex virus (HSV) associated erythema multiforme (HAEM): a viral disease with an autoimmune component Dematol Online J 9 2003 1
18. H. Kokuba, L. Aurelian, and J. Burnett Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-γ is expressed in HAEM lesions and tumor necrosis factor-α in drug-induced erythema multiforme lesions J Invest Dermatol 113 1999 808 815
19. P. Paquet, and G.E. Pierard Erythema multiforme and toxic epidermal necrolysis: a comparative study Am J Dermatopathol 19 1997 127 132
20. S.F. Bean, and R.K. Quezada Recurrent oral erythema multiforme JAMA 249 1983 2810 2812
21. M. Bagot, D. Charue, M. Heslan, J. Wechsler, J.C. Roujeau, and J. Revuz Impaired antigen presentation in toxic epidermal necrolysis Arch Dermatol 129 1993 721 727
22. P.O. Fritsch, and R. Ruiz-Maldonado Stevens-Johnson syndrome-toxic epidermal necrolysis I. Freedberg Fitzpatrick's dermatology in general medicine 5th edition 1999 McGraw Hill 644 654
23. I. Garcia-Doval, L. LeCleach, H. Bocquet, X.L. Otero, and J.C. Roujeau Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 136 2000 323 327
24. B. Rzany, O. Correia, J.P. Kelly, L. Naldi, A. Auquier, and R. Stern Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case controlled study Lancet 353 1999 2190 2194
25. F. Lebargy, P. Wolkenstein, M. Gisselbrecht, F. Lange, J. Fleury-Feith, and C. Delclaux Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study Intensive Care Med 23 1997 1237 1244
26. T. McGee, and A. Munster Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to a regional burn unit Plast Reconstr Surg 102 1998 1018 1022
27. S.L. Engelhardt, M.J. Schurr, and R.B. Helgerson Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage J Burn Care Rehabil 18 1997 520 524
28. E.D. Westly, and H.L. Wechsler Toxic epidermal necrolysis Granulocytic leucopenia as a prognostic indicator 120 1984 721 726
29. I. Viard, P. Wehrli, R. Bullani, P. Schneider, N. Holler, and D. Salomon Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490 493